Skip to main content
Well Lead Medical Co., Ltd. logo

Well Lead Medical Co., Ltd. — Investor Relations & Filings

Ticker · 603309 ISIN · CNE1000021C2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,532 across all filing types
Latest filing 2026-05-21 Notice of Dividend Amou…
Country CN China
Listing Shanghai Stock Exchange 603309

About Well Lead Medical Co., Ltd.

https://www.wellead.com/

Well Lead Medical Co., Ltd. specializes in the research, development, manufacturing, and distribution of medical consumables. The company's product portfolio focuses on clinical areas including anesthesia, urology, respiratory care, and hemodialysis. Key offerings include endotracheal tubes, laryngeal mask airways, Foley catheters, and various drainage systems. Well Lead maintains a strong emphasis on quality management, holding international certifications such as ISO 13485, CE marking, and FDA clearances. The company operates large-scale production facilities equipped with advanced automation to ensure high-volume output and product consistency. Serving a global market, Well Lead provides essential disposable medical devices to hospitals and healthcare providers, positioning itself as a major supplier in the international medical device supply chain.

Recent filings

Filing Released Lang Actions
维力医疗2025年度权益分派实施公告
Notice of Dividend Amount Classification · 92% confidence The document is a formal announcement of the company’s 2025 annual profit distribution (dividend) scheme, specifying per-share cash dividend, record date, ex-dividend date and payment details. This matches the definition of a “Notice of Dividend Amount” (DIV).
2026-05-21 Chinese
《维力医疗董事和高级管理人员薪酬管理制度》(2026年5月修订)
Governance Information Classification · 85% confidence The document is a detailed company policy (“薪酬管理制度”) establishing the internal rules and procedures for director and senior management compensation. It is not an earnings release, proxy, or announcement of board changes, but rather a governance document outlining internal rules, committees, and processes. Therefore, it best fits the Governance Information category (CGR).
2026-05-13 Chinese
北京市中伦(深圳)律师事务所关于维力医疗2025年年度股东会的法律意见书
Regulatory Filings Classification · 30% confidence The document is a legal opinion letter (“法律意见书”) issued by a law firm regarding the procedures, convening qualifications, attendee qualifications, voting processes, and validity of results for the company’s 2025 annual shareholders’ meeting. It is not the AGM presentation materials, not an official standalone voting results announcement (it merely comments on the voting process/results as part of legal advice), and not a financial report or proxy solicitation. It is best classified under “Regulatory Filings” as a miscellaneous compliance/legal document.
2026-05-13 Chinese
维力医疗2025年年度报告
Annual Report Classification · 100% confidence The document is the '2025 Annual Report' (2025年年度报告) for 'Well Lead Medical Co., Ltd' (广州维力医疗器械股份有限公司). It contains comprehensive financial statements, management discussion and analysis (MDA), auditor information, and corporate governance details, spanning 183 pages. It is clearly the full annual report, not an announcement or summary. FY 2025
2026-04-22 Chinese
维力医疗关于2025年度利润分配预案的公告
Notice of Dividend Amount Classification · 90% confidence The document is an official company announcement detailing the proposed 2025 profit distribution (“每股派发现金红利0.3元”), total dividend amount, record date basis, adjustment mechanics, board approval and shareholder meeting requirement. It focuses solely on dividend amounts and related details. This matches the “Notice of Dividend Amount” category.
2026-04-22 Chinese
维力医疗关于向全资子公司提供担保额度的公告
Capital/Financing Update Classification · 85% confidence The document is an official announcement by the listed company’s board on providing guarantee limits to its wholly-owned subsidiaries. It details the guarantee amount, internal approval process, risk disclosures, and board opinions. This is a financing-related corporate action (external guarantee support), not an earnings release, management report, or capital market transaction like share issuance. It best fits under the “Capital/Financing Update” category.
2026-04-22 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.